Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma
- PMID: 28682017
- PMCID: PMC5540990
- DOI: 10.3341/kjo.2016.0067
Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma
Abstract
Purpose: We aimed to examine the clinical features and prognosis of ocular ischemic syndrome and to investigate the risk factors for the development of neovascular glaucoma (NVG).
Methods: The medical records from 25 patients (25 eyes) who were diagnosed with ocular ischemic syndrome were retrospectively analyzed. We recorded the length of time between symptom onset and diagnosis, visual acuity, intraocular pressure, clinical findings of the anterior and posterior segments of the eye, fluorescein angiography, systemic diseases, smoking history, and the extent of any ipsilateral carotid artery stenosis. The risk factors for NVG in patients with ocular ischemic syndrome were investigated.
Results: The mean age was 67.9 ± 12.5 years, and 21 men and 4 women were included in this study. At initial examination, the mean logarithm of the minimum angle of resolution (logMAR) was 2.02 ± 1.26, and the mean intraocular pressure was 21.0 ± 10.3 mmHg. Among 25 eyes of the 25 patients, NVG occurred in 17 eyes after a mean period of 12.6 ± 14.0 months. The length of time between symptom onset and diagnosis (p = 0.025) and the extent of ipsilateral carotid artery stenosis (p = 0.032) were identified as significant risk factors for NVG. At the final follow-up, the mean logMAR visual acuity was 3.13 ± 1.24, showing a poor prognosis regardless of whether NVG occurred.
Conclusions: Overall, the prognosis for ocular ischemic syndrome is very poor. The risk of NVG increases with the length of time between symptom onset and diagnosis, as well as with the severity of ipsilateral carotid artery stenosis.
Keywords: Carotid stenosis; Glaucoma; Neovascular; Ocular ischemic syndrome; Risk factors.
© 2017 The Korean Ophthalmological Society
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28. Ophthalmology. 2008. PMID: 18440643
-
Preliminary clinical analysis of neovascular glaucoma secondary to carotid artery disease.Clin Exp Optom. 2011 Mar;94(2):207-11. doi: 10.1111/j.1444-0938.2010.00555.x. Epub 2010 Dec 22. Clin Exp Optom. 2011. PMID: 21175823
-
Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome.Korean J Ophthalmol. 2009 Jun;23(2):132-4. doi: 10.3341/kjo.2009.23.2.132. Epub 2009 Jun 9. Korean J Ophthalmol. 2009. PMID: 19568367 Free PMC article.
-
Neovascular glaucoma: etiology, diagnosis and prognosis.Semin Ophthalmol. 2009 Mar-Apr;24(2):113-21. doi: 10.1080/08820530902800801. Semin Ophthalmol. 2009. PMID: 19373696 Review.
-
[Neovascular glaucoma--etipathogeny and diagnosis].Oftalmologia. 2012;56(2):3-14. Oftalmologia. 2012. PMID: 23424756 Review. Romanian.
Cited by
-
Clinical Significance of Choroidal Thickness in Eyes with Ocular Ischemic Syndrome.Korean J Ophthalmol. 2022 Feb;36(1):66-73. doi: 10.3341/kjo.2021.0155. Epub 2021 Nov 26. Korean J Ophthalmol. 2022. PMID: 34823342 Free PMC article.
-
Investigation of retinal microcirculation alterations following carotid artery angioplasty and stenting using optical coherence tomography angiography.Front Neurosci. 2025 Mar 19;19:1557062. doi: 10.3389/fnins.2025.1557062. eCollection 2025. Front Neurosci. 2025. PMID: 40177373 Free PMC article.
-
Significant changes of the choroid in patients with ocular ischemic syndrome and symptomatic carotid artery stenosis.PLoS One. 2019 Oct 22;14(10):e0224210. doi: 10.1371/journal.pone.0224210. eCollection 2019. PLoS One. 2019. PMID: 31639146 Free PMC article.
-
Comparison of Methods of Endotamponade Used During 23-Gauge Pars Plana Vitrectomy and the Risk of Raised Intraocular Pressure During 24-Month Follow-Up: A Retrospective Study of 196 Patients.Med Sci Monit. 2019 Dec 7;25:9327-9334. doi: 10.12659/MSM.918114. Med Sci Monit. 2019. PMID: 31811816 Free PMC article.
-
Presentation, etiology and treatment outcome of neovascular glaucoma in Ekiti state, South Western Nigeria.Afr Health Sci. 2021 Sep;21(3):1266-1272. doi: 10.4314/ahs.v21i3.37. Afr Health Sci. 2021. PMID: 35222591 Free PMC article.
References
-
- Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997;104:859–864. - PubMed
-
- Magargal LE, Sanborn GE, Zimmerman A. Venous stasis retinopathy associated with embolic obstruction of the central retinal artery. J Clin Neuroophthalmol. 1982;2:113–118. - PubMed
-
- Lyons-Wait VA, Anderson SF, Townsend JC, De Land P. Ocular and systemic findings and their correlation with hemodynamically significant carotid artery stenosis: a retrospective study. Optom Vis Sci. 2002;79:353–362. - PubMed
-
- Kearns TP. Differential diagnosis of central retinal vein obstruction. Ophthalmology. 1983;90:475–480. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical